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Abstract
Background: p23 belongs to the highly conserved p24 family of type I transmembrane proteins, which participate
in the bidirectional protein transport between the endoplasmic reticulum and Golgi apparatus. Mammalian p23 has
been shown to interact with g-secretase complex, and modulate secretory trafficking as well as intramembranous
processing of amyloid precursor protein in cultured cells. Negative modulation of b-amyloid production by p23 in
cultured cell lines suggested that elevation of p23 expression in neurons might mitigate cerebral amyloid burden.
Results: We generated several lines of transgenic mice expressing human p23 in neurons under the control of
Thy-1.2 promoter. We found that even a 50% increase in p23 levels in the central nervous system of mice causes
post-natal growth retardation, severe neurological problems characterized by tremors, seizure, ataxia, and
uncoordinated movements, and premature death. The severity of the phenotype closely correlated with the level
of p23 overexpression in multiple transgenic lines. While the number and general morphology of neurons in
Hup23 mice appeared to be normal throughout the brain, abnormal non-Golgi p23 localization was observed in a
subset of neurons with high transgene expression in brainstem. Moreover, detailed immunofluorescence analysis
revealed marked proliferation of astrocytes, activation of microglia, and thinning of myelinated bundles in
brainstem of Hup23 mice.
Conclusions: These results demonstrate that proper level of p23 expression is critical for neuronal function, and
perturbing p23 function by overexpression initiates a cascade of cellular reactions in brainstem that leads to severe
motor deficits and other neurological problems, which culminate in premature death. The neurological phenotype
observed in Hup23 mice highlights significant adverse effects associated with manipulating neuronal expression of
p23, a previously described negative modulator of g-secretase activity and b-amyloid production. Moreover, our
report has broader relevance to molecular mechanisms in several neurodegenerative diseases as it highlights the
inherent vulnerability of the early secretory pathway mechanisms that ensure proteostasis in neurons.
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Background
p23 (also termed TMP21, p24c, or p24δ1) belongs to the
p24 family of type-I transmembrane proteins, which
predominantly localize to cis-Golgi and coated protein
complex I (COPI)-coated vesicles. The mammalian p24
family contains 10 proteins that can be grouped into
four subfamilies, termed p24a, b, g, and δ [1,2], whose
main function is to regulate anterograde and retrograde
transport in the early secretory pathway between the
endoplasmic reticulum (ER) and Golgi apparatus [3-7].
Eight of the p24 family proteins, including p23, are ubi-
quitously expressed in mouse tissues. p23/p24δ1 is the
only member of the p24δ subfamily in vertebrates, with
the exception of an amphibian-specific p24δ2 [2].
Embryos with targeted deletion of Tmed10 (the gene
that encodes p23) die at E4.5 prior to implantation,
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demonstrating that p23 function is essential for mouse
embryonic development [8].
Like other p24 proteins, p23 has four recognizable
domains, a Golgi dynamics domain at the N-terminus
followed by a coiled-coil domain, a transmembrane
domain, and a short cytoplasmic tail. The role of p23 in
the budding process of COPI vesicle from the cis Golgi
membrane is well characterized [9]. In addition, p24
family proteins are involved in the export of glycosyl-
phosphatidylinositol anchored proteins, and likely other
select cargo, into COPII vesicles [7]. Finally, p24 pro-
teins are important for maintenance of the ribbon-like
Golgi morphology. When overexpressed in mammalian
cells, exogenous as well as endogenous p23 mislocalized
to the ER, causing expansion and clustering of smooth
ER membranes and fragmentation of Golgi apparatus
[5,6,10]. Partial loss of p23 expression in kidney cells of
p23+/- mice also caused Golgi apparatus to dilate [8].
Thus, both diminution and overexpression of p23
induce changes in Golgi morphology.
A potential new function for p23 in Alzheimer’s dis-
ease (AD) pathogenesis emerged from a study that iden-
tified p23 as a binding partner of g-secretase [11]. g-
secretase is a multi-transmembrane enzyme complex
made of four essential subunits, presenilin, nicastrin,
PEN2, and APH1 [12]. Sequential cleavage of amyloid
precursor protein (APP) by b-site APP cleaving enzyme
BACE1 and then by g-secretase generates b-amyloid
(Ab) peptides, which are deposited in senile plaques
found in brains of individuals with AD [13]. siRNA
knockdown of p23 expression in cultured neuronal and
non-neuronal cells enhances secretory trafficking of
APP as well increased secretion of soluble APP deriva-
tives and Ab, suggesting that p23 is a negative modula-
tor of Ab production [11].
Previously we reported that p23 is widely expressed in
major brain areas, and co-localizes in neurons with g-
secretase core subunits presenilin 1 and nicastrin [14].
Interestingly, the steady-state p23 levels decline during
postnatal development in rat and mouse brain, and are
also reduced in the brains of individuals with AD. Based
on these findings, we suggested that age-related decline
in p23 expression may be an intrinsic factor that signifi-
cantly impacts on APP processing and Ab burden in the
aging nervous system [14]. To test whether cerebral Ab
levels can be manipulated by neuronal overexpression of
p23, we generated multiple lines of transgenic mice that
express human p23 under the control of a neuron-speci-
fic promoter. Here, we report that neuronal overexpres-
sion of p23 causes severe motor dysfunction, growth
retardation, infertility, and early death. Although overt
neuronal loss was not detected, marked proliferation of
astrocytes, activation of microglia, and thinning of mye-
linated bundless in brainstem of Hup23 mice indicate
that neurons overexpressing p23 were indeed subject to
crisis or insult. Our data reveal that regulated p23
expression in neurons is critically important for neuro-
nal function, and our study highlights the risks of neu-
ronal overexpression of p23.
Results
Generation of Hup23 transgenic mice and
characterization of p23 expression
In order to overexpress p23 in neurons, we generated
transgenic mice expressing human p23 (Hup23 mice)
under the transcriptional control of Thy-1.2 promoter,
which drives neuron-specific expression of transgenes
[15-17]. We screened 93 potential founders by PCR, and
identified 22 that harbored the human p23 transgene
(Figure 1A). By crossing each founder with C57BL/6J
mice, we were able to obtain F1 mice harboring the
transgene at the expected Mendelian ratio. We then
analyzed brain lysates of F1 offspring from all 22 trans-
gene positive potential founders for p23 protein expres-
sion. Quantitative Western blots analyses of F1 progeny
of all 22 founders revealed neuronal p23 overexpression
in brains of only six lines (lines 06, 43, 61, 74, 76, and
89). In these lines p23 was overexpressed to different
levels in the forebrain, cerebellum, brainstem, and spinal
cord (Figure 2). Although the level of overexpression
varied between the six Hup23 lines, it was fairly consis-
tent in all transgenic descendants of each founder.
In previous studies Thy-1.2 promoter-driven gene
expression was observed in subsets of cortical, hippo-
campal, cerebellar neurons as well as the majority of
motoneurons and sensory neurons [17]. In agreement,
immunohistochemical analysis using a highly specific
polyclonal p23 antibody [14] showed overall intense p23
staining in brain and spinal cord of Hup23 mice relative
to non-transgenic (Ntg) littermates (Figure 1C). As we
reported earlier, endogenous p23 is expressed mainly in
neurons in rodent brain [14]. Detailed analysis of p23
staining in sagittal sections from Hup23 mice and Ntg
littermates revealed p23 overexpression in neurons
throughout somatomotor, somatosensory, parietal, and
visual cortex, especially in layers IV and V of the cortex
(Figure 3). Intense p23 staining was also observed in
CA1-CA3 pyramidal neurons of the hippocampus, and
in neurons located in the dentate gyrus, hilus, as well as
subiculum. Overall staining intensity was also higher in
the thalamus, hypothalamus, inferior colliculus, and
within the substantia nigra. In the cerebellum, p23 over-
expression was evident in cerebellar Purkinje cells,
molecular and granule cell layers, and in the deep cere-
bellar nuclei. Consistent with immunoblot results,
higher expression of p23 was apparent throughout the
brainstem, particularly in neurons within the pontine
nuclei and superior olivary complex (Figures 1 and 3).
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In the spinal cord, transgene-derived p23 was highly
expressed in neurons of all laminae with the exclusion
of the superficial laminae 1 and 2. Consistent with pre-
vious observations of Thy-1.2 promoter-driven transgene
expression [17], transgenic p23 expression could be
clearly seen in motoneurons in the ventral horn of the
spinal cord (Figure 1C).
Resting tremor, seizure-like activity, motor disorder, and
early death in Hup23 mice
Initially, we noticed that transgenic offspring in Hup23
line 06 displayed abnormal movement and had shorter
life span. As we generated F1 offspring from additional
founders, we observed that Hup23 mice in five addi-
tional lines (lines 43, 61, 74, 76, and 89, all of which had
p23 overexpression) were born normal but developed a
complex motor disorder phenotype with insidious onset
few weeks after birth (see Table 1). Animals exhibited
hunched posture, head bobbing, uncoordinated and
jerky movements, staggered gait, ataxia, exaggerated
movement of the tail, periodic knuckling over of the
front paws, as well as transient and intermittent resting
tremor to occasional seizures. A few of the animals also
exhibited prolonged extension of the tarsus and flexing
of the front digits (clenching). Additional movie files
illustrate these abnormalities [see Additional files 1 and
2]. Every transgenic offspring in each of the six lines
where we observed p23 overexpression and the Hup23
founder #43 developed tremor and movement problems.
Notably, offspring of remaining 16 potential founders
that failed to show p23 overexpression by quantitative
immunoblotting or immunostaining were free of any
symptoms.
The onset of the symptoms varied in each transgenic
line and ranged between P14 and P40 (Table 1). With
the exception of male mice in line 89, all Hup23 Tg
mice died shortly after the onset of the phenotype. The
time interval between the first visible sign of shaking/
shudder phenotype to death varied in each line. In line
61 where the phenotype was most severe, symptoms
appeared at P14 and most animals died by P21. In line
06 where the symptom was milder, a subtle phenotype
was observed around P37, which deteriorated to a visi-
ble phenotype by P45, and death occurred around P60.
Because premature death occurred before the mice
reached sexual maturity, we were unable to generate
Hup23 F2 offspring. The males of Hup23 mice in line
89 were the only ones survived beyond adulthood.
Nevertheless, they also failed to breed beyond F1.
Therefore, all experiments were performed with F1
animals.
The severity of symptoms and the level of p23 expres-
sion appeared to show a high degree of correlation
(Table 1; [see Additional file 1]). Hup23 mice in the two
Figure 1 Generation of Hup23 mice. A, Schematic representation of the transgenic construct. Human p23 was expressed under the
transcriptional control of mouse Thy-1.2 promoter using Thy-1.2 genomic expression cassette. B, Genotyping of Hup23 mice. Genotyping was
performed by PCR of tail DNA using primers specific to human p23 cDNA (upper panel) to amplify a 466-bp PCR product. Control reactions
were performed using primers specific for mouse Tmed10 locus (lower panel) to amplify 712-bp PCR product. C, The distribution of endogenous
and transgene-derived p23. Sagittal brain sections and cross sections of spinal cord from Ntg and Hup23 mice were stained by
immunoperoxidase or immunofluorescence labeling, respectively, using polyclonal p23 antibody. In agreement with the previously described
pattern of transgene expression from the Thy-1.2 genomic expression cassette [15-17], p23 is broadly overexpressed in brain and spinal cord.
Brainstem (Bs), caudate putamen (CP), cerebellum (Cb), cortex (Cx), hippocampus (H), hypothalamus (Hy), midbrain (Mb), substantia nigra (SN),
thalamus (Th), olfactory bulb (OB), and ventral striatum (VS) are indicated in sagittal brain section. Spinal motoneurons (MNs), lateral spinal
nucleus (LSN), rubrospinal tract (RS), lateral funiculus (LF), ventral funiculus (VF), and ventral horn of gray matter (VH) are indicated in spinal cord
sections.
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Figure 2 Overexpression of p23 in forebrain, cerebellum, brainstem, and spinal cord of Hup23 mice. A, Representative Western blots
analysis of steady-state p23 levels in Hup23 mice and littermates. Ninety μg of total protein lysates (or 15 μg in the case of line 61) were
fractionated on 4-20% SDS-PAGE gels and immunoblotted using polyclonal p23, p24 and flotillin-2 antibodies. B, Quantification of p23 levels. The
signal intensity of p23 from multiple animals from each line (normalized to flotillin-2 signal as loading control) was quantified using Odyssey
Imager (LI-COR) and plotted as fold difference in Hup23 mice relative to their Ntg littermates.
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lines with the highest p23 overexpression levels, line 43
and 61, developed more severe symptoms, showed ear-
lier onset, and had shorter life span. The levels of p23
overexpression in line 06 and 89 were not high (~1.2
fold in the forebrain and cerebellum and 1.5 fold in the
brain stem and spinal cord), and yet were sufficient to
cause the impaired movement phenotype.
Postnatal growth retardation in Hup23 mice
Newborn Hup23 mice were similar in size and body
weight as compared with Ntg littermates of the same
sex and weanlings exhibited normal grooming behavior.
However, Hup23 mice failed to gain weight at similar
rates to their Ntg littermates as they aged. We
compared the weight of 14 Hup23 mice from 5 different
lines to their Ntg littermates and found that in each line
juvenile Hup23 mice were smaller in body size and had
lower body weight relative to their Ntg littermates (Fig-
ure 4A and 4B). For instance, Hup23 mice from line 74
showed significant weight difference starting at P32 (p <
0.05 on P32; p < 0.001 on subsequent days). A one-way
ANOVA test of animals from four lines revealed signifi-
cant differences in body weight between Hup23 mice
and corresponding Ntg littermates [F (3, 8) = 39.15, p <
0.0001]. Tukey post-hoc comparisons showed signifi-
cantly lower weights in symptomatic transgenic males (p
< 0.001) as well as females (p < 0.01) as compared with
non-transgenic littermates of the same sex (Figure 4C).
Figure 3 Immunohistochemical analysis of p23 expression. Sagittal brain sections of Hup23 Tg mice and Ntg littermates were stained with
p23 antibody [14]. Shown are pairs of images from transgenic mouse brain (Hup23) and Ntg littermate corresponding to cortex, hippocampus,
CA1 region of the hippocampus (CA1), thalamus (Th), deep cerebellar nuclei (DCN), cerebellum (Cb), and pontine nuclei (PN). p23 localizes to
the cell body and vertically oriented apical dendrites in Hup23 cortex (Cx). The following areas are indicated: DG, dentate gyrus; gcl, granule cell
layer; H, hilus; ml, molecular layer; Pcl, Purkinje cell layer; so, stratum oriens; sp, stratum pyramidale; sr, stratum radiatum; Sb, subiculum.
Table 1 A comparison of p23 overexpression and the onset of phenotype in Hup23 mice
Line Fold overexpression Symptoms observed by DigiGait analysis Symptoms visually observed Age at death
06 1 - 1.5 ~P30 ~P37 ~P60
43 1.4 - 4.9 P20 P22 P33 - 34
61 2.8 - 10.4 N.D. P14 P17 - 21
74 1.3 - 2.5 P28 P32 P43 - 50
76 1.1 - 2.5 P28 P32 P41 - 48
F 1.3 - 1.5 P33 P30 P42 - 44
89
M 1 - 1.4 P40 P36 Survived
N.D. not determined. F, female; M, male.
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The tremoring phenotype and impaired motility might
have contributed to their poor weight gain despite our
attempts to compensate for impaired movement by
making food readily accessible by placing moistened
chow and gel food on the cage floor.
DigiGait analysis of impaired motor function in Hup23
mice
We examined Hup23 mice using the DigiGait Imaging
System in order to detect and quantify impairment in
coordination and motor function in transgenic animals.
The DigiGait system uses high-speed videography to
image the underside of mice as they walk on a motor-
ized transparent treadmill belt. Adult mice move at
velocities of 14 - 43 cm/sec during spontaneous walk/
trot locomotion [18]. The Hup23 mice in each line and
their Ntg littermates were examined at walking speeds
that ranged from 2 - 20 cm/sec as outlined under Mate-
rial and Methods starting at P28 (n = 10) or P20 [for
line 43; n = 4]. The trials were performed every other
day until the mice were unable to run on the treadmill.
In each transgenic line, there was a clear difference
between Hup23 mice and Ntg littermates in all the
parameters, including stride length and frequency.
Before the onset of overt symptoms, transgenic mice
already showed difficulty maintaining their speed and
occasionally galloped by moving the hind limbs synchro-
nously. Additional movie files illustrate these differences
[see Additional files 3 and 4]. Because the motor deficits
were so striking when the treadmill was held at 20 cm/
sec, we resorted to performing trials at progressively
lower treadmill speeds whenever the mice had trouble
running at a given speed, and noted the speed at which
the animals were able to comfortably run for 5 to 10
Figure 4 Movement problem of Hup23 mice. A, Three male F1 littermates of line 06 at the age of P55 are shown for comparison of body
size. B, Progressive decline in body weights in Hup23 animals. The weight of each Hup23 animal was compared to the average weight of its
own Ntg littermate(s) of the same sex, and the mean ± SEM of 4-7 animals from each line are plotted. C, The average body weight of Hup23
mice and their littermates in each line on the last day of measurement (see B) is plotted as mean ± SEM. A one-way ANOVA with Tukey post-
hoc comparison was performed to assess statistical significance. **, p < 0.01; ***, p < 0.001. D, DigiGait analysis. The performance of Ntg mice on
the DigiGait is shown as a black line with open rectangles. Hup23 mice and littermates were subject to DigiGait trial every other day at treadmill
speeds of 20 cm/sec or lower as described under Methods. The animals were tested at lower speeds if they were too impaired to keep up with
the treadmill kept at 20 cm/sec. If a mouse failed to gain speed and run when the treadmill was kept at 5 cm/sec, 0 cm/sec is rendered to that
trial and the animal was not tested any further. Each black circle represents the average speed at which Hup23 mice can run at a given age. The
mean ± SEM of data from 14 Hup23 Tg mice from 4 lines and Ntg littermates is plotted. A one-sample t-test was performed to compare the
speed of Hup23 mice at each age with to the speed of Ntg animal (20 cm/sec). **, p < 0.01; ***, p < 0.0001 for all other ages tested.
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seconds during the trial. In hundreds of trials Ntg litter-
mates regardless of age, gender, or which line they were
from, had no trouble running with the treadmill held at
20 cm/sec. Similarly, Hup23 mice were able to run at
the treadmill speed of 20 cm/sec at P24 and P28. How-
ever, they progressively lost the ability to reach and
keep up with the treadmill speed (Figure 4D; [see Addi-
tional file 5]). Statistical analysis (one-sample t-test)
revealed significant age-associated decline of running
speed in Hup23 mice by P32 (p < 0.01 on P32; p <
0.0001 at all later time points).
Analyzing Hup23 mice using the DigiGait Imaging
System, which measures running and motor activity
parameters with high accuracy, revealed defects in
motor function before visible signs of tremor or other
symptoms related to movement became apparent. For
instance, subtle symptoms in movement were visually
observed in Hup23 line 06 at P37 whereas the motor
deficits were readily observed on DigiGait trial one week
earlier, at P30. A comparison of the level of p23 overex-
pression and the age when Hup23 animals exhibited dif-
ferences in DigiGait treadmill performance is
summarized in Table 1. In general, the higher the p23
expression level the earlier the motor dysfunction was
detected (Table 1).
Normal neuronal morphology in Hup23 mice
To examine the neuronal morphology in Hup23 mice
we performed immunostaining using neuron-specific
markers: neuronal nuclear antigen (NeuN) to stain all
neuronal cells and calbindin D-28K to stain select neu-
ronal populations in the brain including Purkinje cells.
Immunohistochemical staining using antibodies against
NeuN failed to reveal marked differences in staining
intensity or the distribution of NeuN-positive immunor-
eactivity in cortex, hippocampus, cerebellum and brain
stem (Figure 5A). Similarly, Hup23 and Ntg littermates
revealed no marked difference in calbindin staining in
outer layers in cortex, hippocampal mossy fiber term-
inals, cell bodies in the granule cell layer and dendrites
that extended into the molecular layer of dentate gyrus,
Purkinje cells and their dendrites in cerebellum, and
staining along fibers and termini within vestibular
nuclear complex, pontine gray and superior olivary com-
plex in brainstem (Figure 5B). Moreover, TUNEL stain-
ing failed to reveal signs of escalated level of cell death
Figure 5 Immunohistochemical analysis of neuronal markers in Hup23 mice. Sagittal brain sections of Hup23 and Ntg brain were
processed by immunoperoxidase staining with antibodies against NeuN (A) and calbindin (B). Images of cortex and hippocampus, cerebellum,
and brainstem are shown. The following areas are indicated: DG, dentate gyrus; Sb, subiculum; IC, inferior culliculus, PN, pontine nuclei, gcl,
granule cell layer; ml, molecular layer; Pcl, Purkinje cell layer; DCN, deep cerebellar nuclei, SOC, superior olivary complex, SVN, spinal vestibular
nucleus, CN, cuneate nucleus. Note that the overall immunoreactivity for both markers is comparable in Hup23 and Ntg brain.
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in mouse brain upon overexpression of p23 in Hup23
mice (data not shown).
To further characterize neuronal morphology in
Hup23 mice, we performed double-immunofluorescence
staining of p23 and presynaptic marker synaptophysin,
dendritic marker microtubule-associated protein 2
(MAP2), or myelinated axon bundle marker myelin
basic protein (MBP). Confocal microscopy analysis
revealed p23 overexpression throughout the cortex,
especially obvious in large pyramidal neurons (Figure
6A). No discernable difference in the staining pattern or
intensity of presynaptic marker synaptophysin was
observed in the vicinity of neurons overexpressing p23
(Figure 6A). Moreover, similar presynaptic staining was
observed in hippocampal CA1 region, cerebellar Pur-
kinje cell and molecular layers, and brainstem (Figure
6B), despite overall higher p23 expression in Hup23
mice (see Figure 7). MAP2 staining also revealed no
marked difference between Hup23 and Ntg littermates
(not shown).
Since Hup23 mice developed tremor and symptoms
similar to those caused by cerebellar ataxia, we decided
to further characterize Purkinje neurons in cerebellum.
Presynaptic vesicular glutamate transporters (VGLUTs)
are responsible for transport of L-glutamate, the predo-
minant excitatory neurotransmitter in the central ner-
vous system into the synaptic vesicles, and consequently
VGLUT1 and VGLUT2 are used as markers of excita-
tory presynaptic terminals [19]. VGLUT1-deficient mice
exhibit typical neurological phenotypes including unco-
ordinated movement [20], and alterations in VGLUT1
and VGLUT2 expression level have been suggested to
account for the motor deficits observed in Parkinson’s
disease [21]. In this context, we examined by double
immunofluorescence staining the distribution of
VGLUT1 or VGLUT2 along with calbindin in cerebel-
lum of Hup23 mice. This analysis revealed normal
appearance of calbindin staining in the soma and den-
drites of Purkinje neurons, and the expected pattern of
VGLUT1 and VGLUT2 staining in the two excitatory
afferents, with VGLUT1 being localized in parallel fibers
(red, upper panel) and VGLUT2 in dendrites of Purkinje
cells and climbing fibers (red, lower panel) (Figure 6C
and Additional file 6). Thus, overexpression of p23 does
not alter synaptic wiring in cerebellar Purkinje cells and
the distribution of VGLUT1 and VGLUT2 in cerebellar
excitatory afferents of Hup23 Tg mice.
Glial cell activation and defective myelination in
brainstem of Hup23 mice
Since neuronal cells in Hup23 mouse brain seemed to
be normal (i.e. both the number and the morphology of
neuronal cells were not markedly altered), we decided to
stain brain sections with antibodies against non-
neuronal cells. We first examined astrocytes, the most
abundant cell type in the brain. In response to a spec-
trum of brain injury conditions ranging from acute
trauma or stroke to inflammatory conditions and
Figure 6 Analysis of p23 and synaptic marker expression.
Double immunofluorescence analysis was performed on sagittal
brain sections stained with indicated antibodies using confocal
microscopy. A, Pyramidal neurons in frontal cortex of Hup23 mice
show overexpression of p23 (green) and similar presynaptic
distribution of synaptophysin (red). B, Synaptophysin staining in
hippocampal CA1 region, cerebellum, and brainstem appears
indistinguishable between Hup23 and Ntg mice. C, Normal
appearance of Purkinje cells visualized by calbindin staining, as well
as VGLUT1 and VGLUT-2 labeling of parallel fibers and climbing
fibers, respectively, in cerebellum of Hup23 animals. The following
areas are indicated: Pcl, Purkinje cell layer; gcl, granule cell layer, ml,
molecular layer; sp, stratum pyramidale; sr, stratum radiatum.
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neurodegeneration, astrocytes become hypertrophic and
markedly upregulate expression of the intermediate fila-
ment protein GFAP, a process referred to as ‘astroglio-
sis’ [reviewed by [22]]. When we stained brain sections
of Hup23 mice with GFAP antibody, prominent activa-
tion of astrocytes was observed consistently in brain-
stem, inferior colliculus and deep cerebellar nuclei in
each of the six Hup23 lines (Figure 7A and 7B). In
Figure 7 Gliosis in Hup23 Tg mouse brain. A, Sagittal brain sections of Hup23 Tg mice and their Ntg littermates were stained with an
antibody against GFAP. A pair of representative images is shown at lower magnification. B, Higher magnification images of cortex (Cx), superior
colliculus (SC), deep cerebellar nuclei (DCN), and brainstem (Bs) [regions indicated by boxes in panel A] are shown. C, Quantification of
astrogliosis in Hup23 brainstem. The number of star-shaped GFAP positive astrocytes was counted in four defined regions within brainstem (see
the schematics on the left) in Hup23 mice and littermates from 4 different lines, and the mean ± SEM is plotted. Pair wise t-test ***, p < 0.001,
** p < 0.01, * p < 0.05.
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addition, two high expressing Hup23 lines, 43 and 61,
showed activation of astrocytes in cortex (Figure 7A).
Confocal microscopy analysis of sections stained with
p23 and GFAP antibodies revealed neuronal overexpres-
sion of p23 along with robust activation of astrocytes in
brainstem (Figure 8). In contrast, GFAP staining in CA1
region of hippocampus and cerebellum was comparable
between Hup23 and Ntg mice in 4 of the 6 Hup23 lines
(lines 06, 74, 76, and 89) (Figure 8). Quantitative analy-
sis of mice from 4 lines (lines 06, 43, 74 and 89) showed
significant increase in the number of GFAP-positive
astrocytes in brainstem of Hup23 mice as compared to
Ntg littermates (Figure 7C).
The above results are consistent with neuronal p23
overexpression causing certain perturbation of brain-
stem where the highest level of overexpression was
observed. Next, we performed immunofluorescence ana-
lysis of microglia and oligodendrocytes in brains of
Hup23 mice. When the nervous system senses an injury
or signs of neuronal dysfunction, it triggers a rapid cel-
lular response resulting in neuroinflammation mediated
by microglia [23]. Resting microglia are characterized by
small rod-shaped cell body and thin ramified processes
originating from the cell body. The activation of micro-
glial cells in pathological conditions is manifested pri-
marily by their proliferation. Moreover, during the
multistate activation process microglia undergo a series
of changes whereby their cell bodies become rounder
and the processes become thicker [24,25]. When we
stained microglia with an antibody against Iba1, a mar-
ker that recognizes both resting and activated microglia,
we found that microglia in Hup23 mouse brainstem had
typical amoeboid morphology of activated microglia
whereas the microglia in Ntg mouse brainstem were at
resting state (Figure 9). In contrast to astrocytes and
microglia, which proliferate in response to injury or
neuronal dysfunction, oligodendrocytes are vulnerable to
neuronal injury such as inflammation and oxidative
stress. aB-crystallin, a member of the class of small heat
shock proteins, is known to be expressed in oligoden-
drocytes and upregulated under certain pathological
conditions [26]. When we performed double immuno-
fluorescence staining with antibodies against aB-crystal-
lin and GFAP, we observed aB-crystallin staining of
oligodendrocytes in brainstem of Ntg mice but not in
Hup23 mice, despite intense activation of astrocytes
(Figure 9). Similar to what we observed with GFAP
staining, Iba1 and aB-crystallin staining in cortex and
hippocampus were also similar between Ntg and Hup23
mice.
Finally, we stained brains sections with an antibody
against MBP, a major component of myelin and found
that staining intensity and pattern of staining were com-
parable between Hup23 and Ntg littermates in cortex,
hippocampus and cerebellum (Figure 10B and not
shown). In contrast, we observed sparse MBP staining in
brainstem at lower magnification (Figure 10A). Confocal
microscopy at higher magnification clearly shows the
presence of thinner myelinated bundles in brainstem of
Hup23 mice as compared with larger bundles of myeli-
nated axons observed in Ntg mice (Figure 10B). This
difference between Hup23 mice and littermates in MBP
Figure 8 Analysis of p23 and GFAP expression in p23 mice.
Double immunofluorescence analysis was performed on sagittal
brain sections stained with antibodies against p23 (red) and GFAP
(green) using confocal microscopy. GFAP staining in hippocampal
CA1 region and cerebellum appears indistinguishable between
Hup23 and Ntg mice. However, marked gliosis is apparent in
brainstem. Overexpression of p23 is observed in all three areas.
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staining, which is indicative of defective myelin forma-
tion, was observed in brainstems of all Hup23 lines
examined. Thus, in brainstems of Hup23 mice astrocytes
and microglia are activated whereas myelin formation is
partially impaired in response to neuronal overexpres-
sion of p23. Unfortunately, at the time when we discov-
ered this phenotype we were unable to generate any
additional F1 offspring in order to further characterize
hypomyelination or loss of myelinated axons by per-
forming ultrastructural analysis of myelin in Hup23
mice.
p23 overexpression causes Golgi fragmentation
Previously it was reported that overexpression of p23 in
cultured proliferating cells results in fragmentation of
the Golgi apparatus and expansion of smooth ER mem-
branes in a subset of transfected cells [6]. To determine
whether p23 overexpression altered Golgi architecture
in post-mitotic neurons in brain, we performed double
immunofluorescence labeling with antibodies against
p23 and GM130, a cis-Golgi marker. By confocal micro-
scopy, we observed normal Golgi apparatus morphology
and near complete overlap between p23 and GM130
localization in p23 overexpressing pyramidal neurons
located within the cortex and Purkinje neurons in cere-
bellum (not shown). However, in brainstem we found a
subset of neurons located in pontine nuclei and in the
center of pons that contained abnormal p23-positive
structures, which were not labeled by GM130 antibody
(Figure 11A). In these neurons the Golgi apparatus has
lost its characteristic continuous ribbon morphology and
appeared to have undergone fragmentation (Figure 11A).
It is well known that p24 family proteins participate in
bidirectional transport of proteins between the ER and
Golgi, and facilitate ER quality control [3,4,6,7,27].
Moreover, loss of p24 function in yeast causes activation
of the UPR [28]. Therefore, we considered the possibility
that overexpression of p23 might cause protein misfold-
ing and evoke the UPR. To this end, we performed real-
time PCR analysis of mRNA isolated from Hup23 and
Ntg littermate in lines 06, 43, 61, and 74 to assess the
expression of proapoptotic transcription factor CHOP, a
well-characterized target of the mammalian UPR. We
found upregulation of CHOP expression in lines 43 and
61 (the lines with the highest level of Hup23 expres-
sion), but not in lines 06 and 74 (the lines with low
levels of Hup23 expression) (data not shown). To extend
this observation, we performed immunoblot analysis of
ER chaperone GRP78, a well-known marker of the UPR.
In addition, we examined activating transcription factor
ATF4, a protein whose steady-state levels are very low
under normal conditions. In cells experiencing ER stress,
RNA-activated protein kinase-like endoplasmic reticu-
lum kinase PERK induces phosphorylation of eukaryotic
translation initiation factor eIF2a, which facilitates
enhanced translation of Atf4 mRNA through internal
ribosomal entry. ATF4 then activates the upregulation
of a subset of UPR-target genes through a transcrip-
tional cascade involving ATF3 and CHOP [29,30].
Finally, we examined the levels of ER-resident luminal
protein ARP (also called ARMET), which is widely
expressed in the nervous system and upregulated in
neurons by ER stress [31-33]. Immunoblot analysis of
brainstem lysates from all six lines of Hup23 mice
revealed little sign of increased accumulation of these
three UPR-associated proteins (Figure 11B). Collectively,
the results above indicate that high level p23 overex-
pression leads to mislocalization of p23 and Golgi frag-
mentation in a subset of neurons in the brainstem, but
these defects do not lead to overt activation of the UPR.
Discussion
We report here the generation and characterization of
transgenic mice overexpressing human p23 in neurons
Figure 9 Analysis of microglia and oligodendrocytes in Hup23
mice. Double immunofluorescence analysis was performed on
sagittal brain sections stained with antibodies against GFAP (green)
and microglial marker Iba1 or aB-crystallin, which stains
oligodendrocytes in brain (red), using confocal microscopy. Hup23
mice show robust microglial activation but weak aB-crystallin
labeling of oligodendrocytes.
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throughout the central nervous system, under the con-
trol of Thy-1.2 promoter. We found that neuronal over-
expression of p23 in mice causes a complex set of
neurological problems with onset in the first few weeks
after birth, progressive motor deficits, post-natal growth
retardation, infertility, and premature death. Despite this
morbid phenotype, the major brain structures appeared
normal in Hup23 mice, and neurons throughout the
brain and spinal cord had normal morphology when
analyzed by staining with neuronal markers and showed
no overt sign of enhanced apoptosis. However, we
observed striking astrogliosis, activation of microglia and
defects in myelination in brainstem of Hup23 mice.
Furthermore, p23 overexpression led to increased
burden of protein misfolding in the ER as evidenced by
the activation of integrated stress response in brainstem.
These results suggest that p23 function in the early
secretory pathway is critical for neuronal function and
even modest overexpression of this protein is sufficient
to cause deleterious cellular dysfunction, which ulti-
mately manifests as a complex neurological phenotype
in transgenic mice.
p24 family proteins exist and function as stable oligo-
meric complexes, and the stability of each p24 protein
depends on successful heteromeric assembly with other
family members. For example, p23 can exist as mono-
mers, homodimers, and heterodimers with p24, p25, and
p27, but not p26 [34,35]. Knockdown of p23 expression
Figure 10 Abnormal MBP staining in brainstem of Hup23 mice. Double immunofluorescence analysis was performed on sagittal brain
sections stained with antibodies against p23 (red) and MBP (green) using confocal microscopy. A, Representative lower magnification images of
brainstem reveal thinner myelinated bundles in Hup23 brain. B, Higher magnification images of brainstem, staining in hippocampal CA1 region
and cerebellum are shown. Unlike the apparent difference observed in brainstem, MBP staining in hippocampus and cerebellum is comparable
between Hup23 mice and Ntg littermates.
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reduces steady-state levels of p24, p25, p27, and tp24,
supporting their existence as heteromers and their
dependency on each other to form stable complexes
[8,36-38]. Our findings that even modest neuronal over-
expression of p23 (~1.4 fold endogenous levels) elicits a
range of phenotype in transgenic mice, and the severity
of the phenotype correlated well with the level of p23
overexpression, suggest that a delicate balance exists in
the relative abundance of p24 proteins in neurons. In
contrast, mice with targeted deletion of one allele of the
gene encoding p23, which resulted in 70% loss of
steady-state p23 expression, were viable and free of any
neurological deficits [8]. Notably, the steady-state levels
of other p23 family proteins were concomitantly
reduced in heterozygous p23 animals [8]. However, in
Hup23 mice there was virtually no compensatory upre-
gulation of p24 following overexpression of p23, even
when p23 levels were elevated more than 10-fold in the
brainstem of line 61 (Figure 2). This observation is in
agreement with lack of changes in the steady-state levels
of endogenous p24 proteins following transgenic expres-
sion of p24δ1 (p23 orthologue) under the control of the
proopiomelanocortin promoter in the melanotrope cells
of the intermediate pituitary [39]. Therefore, it is possi-
ble that the relative ratio of different p24 family proteins
in certain cell types, such as post-mitotic neurons, is
more critical than the absolute level of individual p24
proteins.
Previous studies have shown that at least two p24
family proteins are essential for mouse embryonic devel-
opment: p23 knockout embryos die at E4.5 prior to
implantation, and p24 knock out embryos die at E10.5
[8,40]. In either case, expression of other p24 family pro-
teins was severely compromised, in agreement with the
notion that steady-state levels of p24 proteins are inter-
dependent and complex formation regulates their stabi-
lity. While it has not been firmly established, it is very
likely that lethality of p23 and p24 knockout embryos is
the consequence of abnormal protein trafficking due to
loss of function of p24 family proteins during early
embryogenesis. In this regard, the Thy-1.2 promoter used
to generate Hup23 mice is known to drive transgene
expression in subsets of neurons as early as E13, although
robust neuronal expression is consistently observed
shortly after birth [15,17]. Our observation that Hup23
mice are normal at birth and showed no symptoms for
the first two weeks after birth indicates that neuronal
overexpression of p23 is not deleterious during late
stages of embryonic and early post-natal development
(Figure 4B). This agrees well with our previous observa-
tions that the steady-state level of endogenous p23 in
mouse brain is high during embryonic development and
on P0, but declines by 50% in the first four weeks after
birth [14]. High-level p23 expression during embryogen-
esis and the time around birth may also be an indication
of a higher demand of select trafficking facilitated by p23
at early stages in life. However, sustained high level neu-
ronal p23 expression during post-natal development in
Hup23 mice, especially at time when endogenous p23
expression begins to decline [14], was deleterious to neu-
ronal functions as evidenced by the complex neurological
phenotype observed in Hup23 mice.
Figure 11 Golgi fragmentation in Hup23 brainstem. A, Double immunofluorescence analysis of Hup23 brains stained with antibodies against
p23 and GM130. Confocal images of neurons in pontine nuclei (upper panels) and a region in the middle of brainstem (lower panels) are
shown. Arrowheads indicate abnormal p23 localization and Golgi fragmentation (visualized by GM130 staining) in neurons expressing high levels
of p23. B, Immunoblot analysis of UPR markers in brainstem of Hup23 mice. Seventy five μg of total protein lysates of brainstem of Hup23 and
non-transgenic littermates were fractionated on 4-20% SDS-PAGE gels and immunoblotted using antibodies against the indicated proteins.
Hsc70 and GAPDH levels served as loading controls. Lysates from mouse embryonic fibroblasts (MEF) exposed overnight to 2 μg/ml tunicamycin
(Tm) were analyzed on the same gels as positive control for the activation of the UPR.
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Confocal microscopy analysis confirmed that p23 is
overexpressed only in neurons in Hup23 mice; prolifer-
ating astrocytes and activated microglia do not show
evidence of p23 overexpression (Figures 6 and 8). Con-
sistent with immunoblot analyses where we quantified
higher steady-state levels of p23 in brainstem of multiple
Hup23 lines, we observed overall higher p23 staining in
neurons in brainstem as compared with pyramidal neu-
rons in cortex and hippocampus. Moreover, while over-
expressed p23 localized to Golgi apparatus in pyramidal
neurons in cortex and hippocampus as well as Purkinje
neurons in cerebellum, a subset of neurons in brainstem
showed p23 staining as clusters that were not labeled by
the cis-Golgi marker GM130 (Figure 11). This later
observation is highly reminiscent of mislocalization of
overexpressed p23 in expanded ER membranes in cul-
tured cells [5,6,10]. We believe that clustering of p23 in
neurons localized in brainstem is simply an outcome of
the overall higher p23 expression in this brain region.
Consequently, we observed adverse cellular reactions
more readily in brainstem, such as extensive astrocyte
proliferation, microglial activation and partial loss of
myelination. How neuronal overexpression instigates
these complex cellular reactions is an interesting ques-
tion. Nevertheless, premature death and the inability to
generate Hup23 F2 offspring curtailed our investigation.
Mapping with greater precision the neuronal population
responsible of the phenotype will require the generation
of additional mouse models to achieve p23 overexpres-
sion in a Cre-dependent manner by crossing transgenic
mice harboring “floxed” p23 expression constructs with
specific driver lines (such as the HB9cre line to direct
p23 overexpression selectively in motoneurons).
While the effect of p23 on protein trafficking has been
primarily investigated in cells where endogenous p23
expression has been silenced using siRNA, overexpres-
sion of p23 in culture cells has also shown to affect pro-
tein trafficking [6,10]. Since overexpression of p23
displaces endogenous p23 from cis-Golgi into clustered
smooth ER membranes, it is likely that normal p23
function in protein trafficking is compromised in cells
upon p23 overexpression. Accumulation of misfolded
protein is a common feature in several neurodegenera-
tive diseases including Huntington’s disease, which is
characterized by motor abnormalities [41]. Furthermore,
ER stress has been implicated in pathogenesis of various
myelin disorders, including Charcot-Marie-Tooth dis-
ease and multiple sclerosis [42]. Therefore we examined
whether UPR is activated following high-level p23
expression in Hup23 animals. Although real-time PCR
analysis showed activation of CHOP expression in two
lines, immunoblot analysis of all six lines failed to
demonstrate steady-state accumulation of UPR asso-
ciated proteins such as GRP78, ATF4 and ARP.
Precisely what effect p23 overexpression has on the neu-
ronal early secretory pathway remains to be investigated.
Nevertheless, results of our analysis clearly shows that
the complex phenotype observed in Hup23 mice can
not be attributed to accumulation of misfolded proteins
to the extent that it triggers robust UPR activation.
Conclusions
Our characterization of neurological phenotype and pre-
mature death in Hup23 mice has broader implications
for AD research. Diminution of p23 expression in cul-
tured cell lines by siRNA increases AD-associated Ab
production, through mechanisms that involve APP traf-
ficking and g-secretase processing of APP-derived C-
terminal fragments [11,37]. Progressive decline in p23
expression one month after birth in mice and lower
steady-state p23 levels in individuals with AD [14]
prompted us to suggest that lower levels of p23 expres-
sion might be a critical factor that modulates the extent
of Ab production, and consequently contribute to dis-
ease pathogenesis. Based on negative regulation of Ab
levels by p23 expression and physiological decline in
p23 expression during aging, it is particularly interesting
to consider increasing p23 expression or enhancing p23
as a potential strategy to reduce cerebral Ab levels.
However, as evidenced by the phenotype of Hup23
mice, pan-neuronal expression has serious conse-
quences. Still, it remains to be determined whether
maintaining high p23 expression in select neuronal
populations, such as neurons in the forebrain, will
attenuate Ab pathology in mouse models of amyloid
deposition while circumventing the phenotypes such as
tremor and uncoordinated movements observed in
Hup23 mice. Results of the present investigation will be
highly instructive for such future efforts.
Methods
Generation of p23 transgenic mice
The cDNA expressing human p23 was subcloned into
the Thy-1.2 genomic expression vector provided by Dr.
P. Caroni (University of Basel, Basel, Switzerland) [15].
The Thy-1.2-Hup23 expression cassette was released by
digestion with EcoRI and PvuI, gel-purified, and injected
into C57BL/6 fertilized oocytes at the Biologicl Sciences
Division Transgenics/ES Cell Technology Mouse Core
Facility at the University of Chicago. Ninety-three
potential founders were generated and screened for the
presence of the transgene by PCR using the following
primers: p23F2702 (5’-ATTGGTCCTTGC-
CATCTCCTTCCA) and p23R3168 (5’-
TTGTTGACTCGTTGGTATCACGCA) corresponding
to sequences within human p23 cDNA. Control reac-
tions were performed using primers Tmed10F (5’-
GGAGGATGAAGAACTGAAGGTCG) and Tmed10R
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(5-TGTTTCTTGGAGGGGCATAGC) to amplify a 712-
bp segment of the endogenous Tmed10 locus. Founders
were bred to C57BL/6J animals and all experiments
described here were performed on F1 offspring. Body
weights of the mice were measured biweekly for line 06,
43, 74, and 76. The weights of littermates of the same
sex were used to calculate the % difference in body
weight over time. The differences in body weight
between Hup23 and Ntg littermates on the last day of
measurement were analyzed by one-way ANOVA and
Tukey post-hoc comparison.
All experiments involving animals were performed
with prior approval from the University of Chicago
Institutional Animal Care and Use Committee in accor-
dance with federal regulations issued by the United
States Department of Agriculture, the National Institutes
of Health Office of Laboratory Animal Welfare, and the
Association for the Assessment and Accreditation of
Laboratory Animal Care International.
DigiGait analysis
The DigiGait trials were performed on a total of 14
Hup23 mice and 11 Ntg littermates every other day
using DigiGait™ Imaging System (Mouse Specifics, Inc.)
until the Hup23 mice were not able to run or died
between trials. At their first trials, mice were trained to
run on the treadmill by gradually increasing the speed
of the treadmill from 2 to 5, 10, and eventually 20 cm/
sec. In a test trial, a mouse ran in the treadmill at a cer-
tain speed for about 5 seconds. If a mouse can keep up
with the treadmill, the speed of the treadmill was
recorded as the running speed of the mouse. If a mouse
failed to gain speed and run, the trial was repeated after
5 min with the treadmill held at the next lower speed.
All Ntg mice were able to run at the speed of 20 cm/sec
at all ages tested. Therefore, a one-sample t-test was
performed to calculate statistical difference between the
treadmill speeds of Hup23 and Ntg mice.
Antibodies
Rabbit polyclonal p23 antisera against mouse p23 (resi-
dues 32-57) and flotillin-2, and guinea pig GRP78 anti-
body have been described [37,43,44]. Polyclonal p24
antiserum was raised against a glutathione S-transferase
fusion protein corresponding to residues 30-201 of
human p24A. Polyclonal ARP antiserum was raised
against a synthetic peptide corresponding to the C-term-
inal 29 amino acids of mouse ARP. The following com-
mercially available antibodies were used in this study -
mAb: synaptophysin, MAP2 and GFAP (Sigma), NeuN
(Chemicon), MBP (Covance), GM130 (BD Transduction
Laboratories), ATF4 and Hsc70 (Santa Cruz Biotechnol-
ogy), GAPDH (Abcam); polyclonal antibodies: Calbin-
din-D-28K (Sigma), VGLUT1 and VGLUT2 (Millipore),
GFAP (Dako), Iba1 (Wako), and anti aB-crystallin
(Serotec).
Immunohistochemistry and immunofluorescence staining
Mice were anesthetized by isoflurane inhalation before
perfusion with ice-cold PBS. Mouse brains and spinal
cords were harvested and kept on ice. Brains were cut
midsagittally, and one half was further dissected into
forebrain, brainstem, and cerebellum and stored at -80°
C for use in Western blot analysis. The other half of
brain and spinal cord were immersion fixed in 4% par-
aformaldehyde for 48 h and cryoprotected in PBS con-
taining 30% sucrose. Thirty μm-thick sections were cut
on a cryostat and processed following a free-floating
procedure for either enzyme-linked immunoperoxidase
or double-immunofluorescence staining essentially as
described previously [37]. Immunoperoxidase stained
sections were examined under a Zeiss Axioplan 2
microscope and images were acquired using an Axio-
Cam color camera (Carl Zeiss). Alternatively, stained
sections were imaged on a CRi Pannoramic Scan
Whole Slide Scanner (Cambridge Research and Instru-
mentation) using 40 × 0.95 NA LWD Zeiss objective
and Allied Vision Technologies Stingray F146C, 4.6
μm pixel size color camera. Tiled images were ana-
lyzed using 3DHistech software (Cambridge Research
and Instrumentation). Images of fluorescence staining
were acquired on a Leica SP5 Confocal microscope
using 10 × (0.4 NA), 20 × (0.7 NA), 63 × (1.4 NA), or
100 × (1.46 NA) objectives and processed using ImageJ
software [45]. Identical settings were used between Ntg
and Hup23 samples for image acquisition and
processing.
Western blot analysis
Detergent lysates of dissected brain regions and spinal
cord were prepared as described previously [46]. Fifteen
or ninety μg of total protein were separated on 4-20%
SDS-PAGE gels and transferred to Immobilon-FL trans-
fer membranes (Millipore). The membranes were
blocked, incubated in primary antibodies for 2 h, and
IRDye 800CW donkey anti-rabbit IgG (LI-COR Bios-
ciences) for 1 h, and scanned using Odyssey Imager (LI-
COR Biosciences). The blots were probed with p23, p24,
and flotillin-2 antibodies. p23 signal intensities were
normalized to flotillin-2 signals. Two-fold dilutions of
line 61 brain lysates were used to ensure accurate quan-
tification of signal intensities. Seventy five μg of total
protein were used for the analysis of UPR markers and
the blots were developed using chemiluminescence.
RT-PCR and real-time PCR
Total RNA was isolated from homogenized brainstem
using Trizol reagent (Invitrogen) and RNeasy Mini Kit
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(Qiagen). cDNA was synthesized using SuperScript III
First-Strand Synthesis System (Invitrogen). Real-Time
PCR was performed using SYBR GreenER qPCR Super-
Mix (Invitrogen) on iCycler iQ Real-Time PCR Detec-
tion System (BIO-RAD). Melting curve analysis was
used to identify the PCR products and EfficiencyΔΔCt
method was used to quantify the relative abundance of
Ddit3 mRNA using Gapdh mRNA levels as control [47].
The primers used are as follows: Ddit3 (CHOP) 5’
GTCCAGCTGGGAGCTGGAAG and 5’




Additional file 1: Neurological defects in Hup23 mice from 6
transgenic lines. Hup23 mice from 6 transgenic lines display similar
neurological defects with different levels of severity depending on the
level of transgene expression. The videos were recorded on the days
indicated in each panel.
Additional file 2: Side view of Hup23 line 43 mouse on a stationary
DigiGait treadmill. A closer view of Hup23 mouse from line 43
displaying the complex neurological defects (right) and its Ntg littermate
(left). The videos were recorded on P30 when the animals were placed
on a stationary DigiGait treadmill.
Additional file 3: Side view of Hup23 line 43 mouse running on
DigiGait treadmill. Side view of Hup23 mouse from line 43 and Ntg
littermate running on the DigiGait treadmill held at the speed of 20 cm/
sec. The videos were recorded on P30.
Additional file 4: Bottom view of Hup23 line 74 mouse running on
DigiGait treadmill. Bottom view of a Hup23 mouse from line 74 and
Ntg littermate running on the DigiGait treadmill held at the speed of 20
cm/sec. The videos were recorded on P30.
Additional file 5: Rapid decline of Hup23 line 74 mouse
performance on DigiGait treadmill. The same Hup23 mouse from line
74 shows declined performance on the treadmill over a period of 6 days.
The videos were recorded on P30 (top), P35 (middle), and P41 (bottom).
Note that the treadmill is held at different speeds.
Additional file 6: Analysis of p23 and synaptic marker expression.
Double immunofluorescence analysis of calbindin and VGLUT1 or VGLUT-
2 labeling in cerebellum of non-transgenic animals. The following areas
are indicated: Pcl, Purkinje cell layer; gcl, granule cell layer, ml, molecular
layer.
List of abbreviations
Hup23 mice: human p23 transgenic mice; COPI: coated protein complex I;
ER: endoplasmic reticulum; AD: Alzheimer’s disease; APP: amyloid precursor
protein; Aβ: β-amyloid; UPR: unfolded protein response; Ntg: non-transgenic;
NeuN: neuronal nuclear antigen; MAP2: microtubule-associated protein 2;
MBP: myelin basic protein; VGLUT: vesicular glutamate transporter.
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